期刊文献+

微剂量肝素联合冷沉淀治疗新生儿弥散性血管内凝血55例疗效分析 被引量:8

The curative effect of micro-dose heparin combined with cryoprecipitate in treating neonatal DIC
下载PDF
导出
摘要 目的探讨微剂量肝素联合冷沉淀治疗新生儿弥散性血管内凝血(DIC)的疗效。方法选择我院2010~2012年确诊为DIC病例共45例,在积极治疗原发病的同时,给予微剂量肝素[24 U/(kg.d)]皮下注射及联合输注冷沉淀治疗。结果 45例于用药后48 h内凝血功能恢复正常,血小板平均于4d内恢复正常,4例死亡,1例因病情重家属放弃抢救并出院,总有效率88.8%,用药后与用药前比较差异具有统计学意义(P<0.05)。结论微剂量肝素联合冷沉淀治疗弥散性血管内凝血安全有效。 Objective To investigate the efficacy of micro-dose heparin combined with cryoprecipitate in treating neonatal disseminated intravascular coagulation(DIC).Methods In this study,we observed 45 cases of patients diag nosed DIC in our hospital from 2010 to 2012,while the aggressive treatment of the primary disease(while curing the primary disease),we also carry out micro-dose 24U/(kg.d) heparin by subcutaneous injection and united infusion of cryoprecipitate.Results The coagulation function of 45 cases returned back to normal level within the 48 hours after administration.Platelets restored to normal in four days.4 cases were dead,one case gave up to further rescuing and left hospital because of badly condition,the total rate of efficiency was 88.8%.Conclusion The micro-dose heparin combined with cryoprecipitate are safe and effective in curing disseminated intravascular coagulation.
出处 《中国现代医生》 2013年第10期119-120,共2页 China Modern Doctor
关键词 肝素 冷沉淀 新生儿弥散性血管内凝血 Heparin Cryoprecipitate Neonatal disseminated intravascular coagulation
  • 相关文献

参考文献7

  • 1Taylor FBJ,Toh CH,Hoots WK,et al. Towards definition ,clinical and laboratoratory criteria,and a scoring system for disseminated intravas- cular coagulation[J]. Thromb Haemost ,2001, 86(5) : 1327-1330.
  • 2邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M].第4版.北京:人民卫生出版社,2011:872.
  • 3陈自励.李风英.新生儿临床用药[M].第2版;北京:人民卫生出版社.2008:308-310.
  • 4Azzopardi D, Strohm B, Linsell L, et al: Implementation and conduct of therapeutic hypothermia for perinatal asphyxial encephalopathy in the UK--analysis of national data[J]. PLo S One,2012, 7(6):38504.
  • 5Donovan AL, Flexman AM, Gelb AW. Blood pressure management in stroke[J]. Curr Opin Anaesthesiol, 2012, 25 (5) : 516-522.
  • 6李著华,朱庆平,唐显玲,张英,邹平.微量肝素对家兔DIC时血液流变性变化和微循环障碍的治疗作用[J].中国血液流变学杂志,2003,13(3):203-206. 被引量:8
  • 7张熊.血浆凝血因子Ⅷ和D-二聚体测定对重症肝炎时并发DIC的鉴别意义[J].浙江临床医学,2012,14(3):302-303. 被引量:9

二级参考文献12

  • 1陈再英,钟南山.内科学.第7版.北京:人民卫生出版社,2009:352.
  • 2杨绍基,任红.传染病学.第7版.北京:人民卫生出版社,2009.36.
  • 3陈文彬,潘祥林.诊断学.第7版.北京:人民卫生出版社,2009.306.
  • 4Desai UR, Petitou M, Bjork I, et al. Mechanism of heparin activation of antithrombin: role of individual residues of the pentasaccharide activating sequence in the recognition of native and acticated states of antithrombin[J]. J Bid Chem,1998: 273: 7478.
  • 5Hansen JB, Svensson B, Sandset PM, et al. Reduction of factor FⅦ a activity during heparin therapy, evidence for assay interactions with tissue factor pathway inhibitor and antithrombin[J].Thromb Res, 2000, 111(5): 389.
  • 6Mine S, Yamazaki T, Miyata T, et al. Structural mechanism for heparin-binding of the third kunitz domain of human tissue factor pathway inhibitor[ J ]. Biochemistry, 2002, 41 ( 1 ) :78.
  • 7Msaroufi RM, Jozefowicz M, Tapen BJ, et al. Mechanism of thrombin inhibition by antithrombin and heparin cofactor Ⅱ in the presence of heparin[J]. Biomaterials, 1997,18(3):203.
  • 8Xie X, Thorlacius H, Raud J, et al. Inhibitory effect of locally administered heparin on leukocyte wiling and chemoattractant-induced firm adhesion in rat mesenteric venules in vivo[J]. Br. J Pharmacol, 1997, 122(5): 906.
  • 9Hieber LM, Liu JM. Heparin protects cultured arterial endothelial cells from damage by toxic oxygen metabulits[J].Atherosclerosis, 1990, 83(1): 47.
  • 10唐显玲,徐亮.微量肝素预防外科DIC的临床研究[J].临床外科杂志,2000,8(3):152-153. 被引量:4

共引文献392

同被引文献56

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部